Full text is available at the source.
Abstract
Somatic genomic mosaicism may contribute to chronic kidney disease (CKD) progression.
- The study aims to evaluate the role of somatic genomic mosaicism in CKD.
- Evidence will be graded by strength to assess its contribution to disease progression.
- Mosaicism within kidney tissue will be differentiated from clonal changes in blood.
Simplified